Outcomes after warfarin initiation in a cohort of hemodialysis patients with newly diagnosed atrial fibrillation

American Journal of Kidney Diseases

Volumn 66, Issue 4, 2015, Pages 677-688

  Shen, Jenny I ^a,b   Montez Rath, Maria E ^a   Lenihan, Colin R ^a   Turakhia, Mintu P ^a,c   Chang, Tara I ^d   Winkelmayer, Wolfgang C ^a,c  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HARBOR UCLA MEDICAL CENTER   (United States)

^c Division of Cardiovascular Medicine   (United States)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

atrial fibrillation (AF); bleeding; cardiac arrhythmia; Dialysis; drug safety; end stage renal disease (ESRD); hemodialysis; hemorrhagic stroke; ischemic stroke; mortality; oral anticoagulation; prevention; warfarin

Indexed keywords

ANTICOAGULANT AGENT; ANTILIPEMIC AGENT; ANTITHROMBOCYTIC AGENT; CALCIUM ACETATE; DIURETIC AGENT; NITRATE; NONSTEROID ANTIINFLAMMATORY AGENT; SEVELAMER; STATIN (PROTEIN); WARFARIN;

ADULT; AGED; ANTICOAGULATION; ARTICLE; ATRIAL FIBRILLATION; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CARDIOVASCULAR MORTALITY; COHORT ANALYSIS; DRUG WITHDRAWAL; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEMODIALYSIS; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PRESCRIPTION; UNITED STATES; CAUSE OF DEATH; COMPARATIVE STUDY; FACTUAL DATABASE; FOLLOW UP; KAPLAN MEIER METHOD; KIDNEY FAILURE, CHRONIC; MIDDLE AGED; ORAL DRUG ADMINISTRATION; PROCEDURES; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; RISK ASSESSMENT; STROKE; SURVIVAL RATE; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; AGED; ANTICOAGULANTS; ATRIAL FIBRILLATION; CAUSE OF DEATH; COHORT STUDIES; DATABASES, FACTUAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIER ESTIMATE; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RENAL DIALYSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; STROKE; SURVIVAL RATE; TREATMENT OUTCOME; WARFARIN;

EID: 84942295628     PISSN: 02726386     EISSN: 15236838     Source Type: Journal    
DOI: 10.1053/j.ajkd.2015.05.019     Document Type: Article

References (36)

1. A.S. Go, D. Mozaffarian, V.L. Roger, and et al. Heart disease and stroke statistics - 2014 update: a report from the American Heart Association Circulation 129 2014 e28 e292
2. A. Alonso, F.L. Lopez, K. Matsushita, and et al. Chronic kidney disease is associated with the incidence of atrial fibrillation: the Atherosclerosis Risk in Communities (ARIC) Study Circulation 123 2011 2946 2953
3. B.A. Goldstein, C.M. Arce, M.A. Hlatky, M. Turakhia, S. Setoguchi, and W.C. Winkelmayer Trends in the incidence of atrial fibrillation in older patients initiating dialysis in the United States Circulation 126 2012 2293 2301
4. J.P. Piccini, B.G. Hammill, M.F. Sinner, and et al. Incidence and prevalence of atrial fibrillation and associated mortality among Medicare beneficiaries, 1993-2007 Circulation Cardiovasc Qual Outcomes 5 2012 85 93
5. V. Fuster, L.E. Ryden, D.S. Cannom, and et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society Circulation 114 2006 e257 e354
6. K.E. Chan, J.M. Lazarus, R. Thadhani, and R.M. Hakim Warfarin use associates with increased risk for stroke in hemodialysis patients with atrial fibrillation J Am Soc Nephrol 20 2009 2223 2233
7. V. Wizemann, L. Tong, S. Satayathum, and et al. Atrial fibrillation in hemodialysis patients: clinical features and associations with anticoagulant therapy Kidney Int 77 2010 1098 1106
8. W.C. Winkelmayer, J. Liu, S. Setoguchi, and N.K. Choudhry Effectiveness and safety of warfarin initiation in older hemodialysis patients with incident atrial fibrillation Clin J Am Soc Nephrol 6 2011 2662 2668
9. M. Shah, M. Avgil Tsadok, C.A. Jackevicius, and et al. Warfarin use and the risk for stroke and bleeding in patients with atrial fibrillation undergoing dialysis Circulation 129 2014 1196 1203
10. C.A. Herzog, R.W. Asinger, A.K. Berger, and et al. Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO) Kidney Int 80 2011 572 586
11. C.T. January, L.S. Wann, J.S. Alpert, and et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society J Am Coll Cardiol 64 21 2014 e1 e76
12. T.I. Chang, D. Shilane, D.S. Kazi, M.E. Montez-Rath, M.A. Hlatky, and W.C. Winkelmayer Multivessel coronary artery bypass grafting versus percutaneous coronary intervention in ESRD J Am Soc Nephrol 23 2012 2042 2049
13. J.Y. Yang, T.C. Lee, M.E. Montez-Rath, and et al. Trends in acute nonvariceal upper gastrointestinal bleeding in dialysis patients J Am Soc Nephrol 23 2012 495 506
14. R. Pisters, D.A. Lane, R. Nieuwlaat, C.B. de Vos, H.J. Crijns, and G.Y. Lip A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey Chest 138 2010 1093 1100
15. A.S. Go, E.M. Hylek, Y. Chang, and et al. Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice? JAMA 290 2003 2685 2692
16. P.C. Austin Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples Stat Med 28 2009 3083 3107
17. J.M. Robins, M.A. Hernan, and B. Brumback Marginal structural models and causal inference in epidemiology Epidemiology 11 2000 550 560
18. S.R. Cole, and M.A. Hernan Constructing inverse probability weights for marginal structural models Am J Epidemiol 168 2008 656 664
19. V.S. Harder, E.A. Stuart, and J.C. Anthony Propensity score techniques and the assessment of measured covariate balance to test causal associations in psychological research Psychol Methods 15 2010 234 249
20. Leuven E, Sianesi B. PSMATCH2: Stata module to perform full Mahalanobis and propensity score matching, common support graphing, and covariate imbalance testing. 2003. http://ideas.repec.org/c/boc/bocode/s432001.html. Accessed January 10, 2014.
21. S.T. Normand, M.B. Landrum, E. Guadagnoli, and et al. Validating recommendations for coronary angiography following acute myocardial infarction in the elderly: a matched analysis using propensity scores J Clin Epidemiol 54 2001 387 398
22. R.G. Hart, O. Benavente, R. McBride, and L.A. Pearce Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis Ann Intern Med 131 1999 492 501
23. J.I. Shen, M.P. Turakhia, and W.C. Winkelmayer Anticoagulation for atrial fibrillation in patients on dialysis: are the benefits worth the risks? Curr Opin Nephrol Hypertens 21 2012 600 606
24. C. Nimmo, M. Wright, and D. Goldsmith Management of atrial fibrillation in chronic kidney disease: double trouble Am Heart J 166 2013 230 239
25. C.M. Clase, R.M. Holden, M.M. Sood, and et al. Should patients with advanced chronic kidney disease and atrial fibrillation receive chronic anticoagulation? Nephrol Dial Transplant 27 2012 3719 3724
26. S.L. Seliger, D.L. Gillen, W.T. Longstreth Jr., B. Kestenbaum, and C.O. Stehman-Breen Elevated risk of stroke among patients with end-stage renal disease Kidney Int 64 2003 603 609
27. S. Juma, B.K. Thomson, C.E. Lok, C.M. Clase, P.G. Blake, and L. Moist Warfarin use in hemodialysis patients with atrial fibrillation: decisions based on uncertainty BMC Nephrol 14 2013 174
28. W.C. Winkelmayer, J. Liu, A.R. Patrick, S. Setoguchi, and N.K. Choudhry Prevalence of atrial fibrillation and warfarin use in older patients receiving hemodialysis J Nephrol 25 2012 341 353
29. J.B. Olesen, G.Y. Lip, A.L. Kamper, and et al. Stroke and bleeding in atrial fibrillation with chronic kidney disease N Engl J Med 367 2012 625 635
30. J.J. Carrero, M. Evans, K. Szummer, and et al. Warfarin, kidney dysfunction, and outcomes following acute myocardial infarction in patients with atrial fibrillation JAMA 311 2014 919 928
31. R.M. Holden, G.J. Harman, M. Wang, D. Holland, and A.G. Day Major bleeding in hemodialysis patients Clin J Am Soc Nephrol 3 2008 105 110
32. K.E. Chan, J.M. Lazarus, R. Thadhani, and R.M. Hakim Anticoagulant and antiplatelet usage associates with mortality among hemodialysis patients J Am Soc Nephrol 20 2009 872 881
33. T.I. Chang, and W.C. Winkelmayer Comparative effectiveness research: what is it and why do we need it in nephrology? Nephrol Dial Transplant 27 2012 2156 2161
34. W.A. Ray Evaluating medication effects outside of clinical trials: new-user designs Am J Epidemiol 158 2003 915 920
35. US Census Bureau GD. Census Bureau Regions and Divisions with State FIPS Codes. http://www.census.gov/geo/www/reg-div.txt. Accessed January 5, 2012.
36. G.Y. Lip, R. Nieuwlaat, R. Pisters, D.A. Lane, and H.J. Crijns Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro Heart Survey on Atrial Fibrillation Chest 137 2010 263 272